Zhonghong Pulin

Founder and Chairman Sang Shujun is the legal representative and controlling figure behind the group's corporate and investment activities. The firm has not publicly disclosed a dedicated investment committee or separate CIO structure, suggesting decisions flow through the chairman's office. Sang's parallel role as Vice Chairman of the Hebei Province Federation of Industry and Commerce provides direct access to provincial industrial policy networks.

The venture arm draws capital from the group's operating businesses rather than external limited partners. Core cash flows come from medical glove manufacturing and a portfolio of industrial and commercial real estate holdings in Hebei, Jiangxi, and Sichuan provinces. This corporate venture structure means deployment pace and check sizes likely correlate with manufacturing margins rather than fund cycles.

Zhonghong Pulin operates as a direct corporate investor without a disclosed fund-of-funds or LP commitment program. The firm places both early-stage and expansion-stage bets, functioning more like a strategic corporate venture arm than an institutional fund manager. No separate limited partnership vehicles have been announced in public record.

Xiamen ITG Holding Group is a state-owned joint venture partner and major shareholder in the Zhonghong Pulin group. The partnership links the firm to state capital and supply-chain networks, particularly relevant given Xiamen ITG's presence in global commodities and healthcare logistics. The specific equity split and governance terms have not been publicly disclosed.

The firm has not published negative investment screens. Observed investment activity concentrates on healthcare, medical consumables, and adjacent life sciences sectors — consistent with an industrial logic of backing companies that can utilize existing manufacturing and distribution infrastructure. No public record indicates activity in consumer internet, financial technology, or software.

The group supports Zhonghong Pulin Charity Initiatives as a distinct philanthropic vehicle. Details on governance, endowment size, or grant-making focus areas remain undisclosed in public record. The charitable arm appears to operate alongside, but structurally separate from, the corporate venture investment activities.

No co-investment activity with third-party general partners has been documented in public record. The firm's corporate structure and absence of fund marketing suggest it invests solely off its own balance sheet. Any GP relationships would likely center on direct deal-level collaboration rather than fund commitments, though no such arrangements have been reported.